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Key points summary 
 Sodium channels are critical for supporting fast action potentials in neurons. Even mutations 
which cause small changes in sodium channel activity can have devastating consequences for 
the function of the nervous system.  
 Alternative splicing also changes the activity of sodium channels, and while it is highly 
conserved, it is not known whether functional role of this splicing is also conserved.  
 Our data reveal that splicing has a highly conserved impact on the availability of sodium 
channels during trains of rapid stimulations, and suggest that in one mammalian channel, 
Nav1.1 encoded by SCN1A, the increased availability of one splice variant is detrimental.  
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 A model reproducing the effects of splicing on channel behavior suggests that the voltage 
sensor in the first domain is a rate limiting step for release of the inactivation domain, and 
highlights the functional specialization of channel domains. 
 
Abstract  
Voltage-gated sodium channels are critical for neuronal activity, and highly intolerant to variation. 
Even mutations that cause subtle changes in the activity these channels are sufficient to cause 
devastating inherited neurological diseases, such as epilepsy and pain. However, these channels do 
vary in healthy tissue.  Alternative splicing modifies sodium channels, but the functional relevance 
and adaptive significance of this splicing remain poorly understood. Here we use a conserved 
alternate exon encoding part of the first domain of sodium channels to compare how splicing modifies 
different channels, and to ask whether the functional consequences of this splicing have been 
preserved in different genes. Although the splicing event is highly conserved, one splice variant has 
been selectively removed from Nav1.1 in multiple mammalian species, suggesting that the functional 
variation in Nav1.1 is less well-tolerated. We show for three human channels (Nav1.1, Nav1.2 and 
Nav1.7) splicing modifies the return from inactivated to deactivated states, and the differences 
between splice variants are occluded by antiepileptic drugs that bind to and stabilize inactivated states.  
A model based on structural data can replicate these changes, and indicates that splicing may exploit a 
distinct role of the first domain to change channel availability, and that the first domain of all three 
sodium channels plays a role in determining the rate at which the inactivation domain dissociates. 
Taken together, our data suggest that the stability of inactivated states is under tight evolutionary 
control, but that in Nav1.1 faster recovery from inactivation is associated with negative selection in 
mammals.  
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Abbreviations list 
Nav1 = the IUPHAR abbreviation for voltage dependent sodium channels 
SCN = the human genome organization approved prefix for sodium channel subunit genes 
S1-S6 = transmembrane segments 1-3 within voltage sensing sodium channel domains 
D1-D4 = domains 1-4 within voltage sensing sodium channels 
A exon and N exon = the two mutually exclusive 92 nucleotide long cassette exons conserved in 
neuronal sodium channels. The A exon occurs prior to the N exon in genomic sequences. 
 
Introduction  
The vast majority of mammalian genes are modified by alternative splicing, but in most cases the 
adaptive significance of this phenomenon is unknown (Gerstein et al., 2014; Kelemen et al., 2013; Raj 
and Blencowe, 2015). A challenge in elucidating the functional impact of splicing on protein function 
is that it can be difficult to differentiate epiphenomena from changes that are biologically important. 
Alternative splicing that is conserved across multiple genes that diverged from a common ancestor 
offers an opportunity to identify changes in function that have adaptive significance (Abascal et al., 
2015; Kopelman et al., 2005; Su et al., 2006). 
Here, we have focused on the sodium channel family where an alternative splicing event emerged 
early in vertebrate evolution (Copley, 2004) and has been conserved in the face of repeated 
duplication and specialization of the genes (Zakon, 2012). The sequences of the SCNxA genes (x = 1 – 
5, 7 – 11) have diverged to serve different functions in the nervous system (Catterall, 2014; Waxman, 
2007). In mammalian genomes, six different neuronal sodium channel genes have preserved an 
alternative splicing event that consistently changes one amino acid in a short extracellular linker 
immediately before the voltage sensor in the first domain (DIS3-S4, Figure 1). The two splice variants 
are designated „N‟ and „A‟ as initial studies indicated that, although both splice variants co-exist, the 
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„N‟ variant may be enriched in neonatal tissue, while the „A‟ variant tends to predominate in adult 
tissue (Gazina et al., 2010).  
In spite of the conservation of this splicing among sodium channel genes, both humans (Heinzen et 
al., 2007) and rodents (Gazina et al., 2010) contain genetic variations in one gene, SCN1A, that are 
predicted to reduce the expression of the N exon, either because of a splice site polymorphism 
(human) or the presence of stop codons (rodents). There are three possibilities behind the loss of this 
otherwise highly conserved exon from this particular sodium channel gene. Firstly, it may be a 
coincidence that is only present in human and rodent SCN1A genes, but not seen in other species. 
Alternatively, the change imposed by the N exon may have a deleterious effect on the intrinsic 
properties of the channels encoded by SCN1A, which are different from the effects imposed in other 
sodium channels where the N exon is preserved. Finally, splicing may have the same effects in 
different channels, but in SCN1A those effects may have adverse consequences in neuronal networks, 
because SCN1A is preferentially expressed in a different subset of neurons.   
To test these three possibilities, we selected three sodium channels (SCN1A, SCN2A and SCN9A 
encoding NaV1.1, 1.2 and 1.7, respectively), which predominate in different types of neurons: SCN1A 
is especially important in inhibitory neurons, SCN2A in excitatory neurons, and SCN9A in pain-
sensing neurons of the peripheral nervous system. These genes are also associated with distinct 
neurological diseases in humans, including different genetic epilepsies (SCN1A and SCN2A) and pain 
disorders (SCN9A) (Catterall, 2014; Waxman, 2007).  
Sodium channel genes are already known to be highly intolerant to change. The recently published 
ExAC database indicates that SCN1A has a Z score of 5.61 for missense changes, indicating it is more 
than 5 standard deviations below the average number of expected missense changes for a gene of this 
size(Lek et al., 2016). SCN2A is even more extreme, with a Z score of 6.58, while SCN9A, in 
contrast is not tightly constrained with a Z score of -0.69. For SCN2A, the majority of mutations 
associated with epilepsies seem to introduce gain of function changes to the channels (Liao et al., 
2010; Scalmani et al., 2006) with few truncations reported. For SCN1A the story may be more mixed. 
In addition to the epilepsies associated with haploinsufficiency or missense mutations, including some 
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with relatively subtle effects (Catterall, 2014), severe migraine may be caused by gain of function 
missense mutations (Cestèle et al., 2013). Thus SCN1A may be unusual in sodium channels because 
of the association of both subtle increases and decreases in function to disease.  
We report that loss of the N exon in SCN1A is not confined to humans and rodents, but represents a 
broad trend in mammals. By directly comparing N and A variants of all three sodium channels, we 
reveal that alternative splicing has a conserved biophysical function in this gene family. We show that 
the N exon robustly increases channel availability after brief depolarizations compared to the A exon, 
which inserts a negatively charged aspartate residue in the extracellular S3-S4 linker. The N splice 
variants of all three channels are therefore more able to respond to high frequency stimulations. The 
conserved functional impact of splicing suggests that the loss of exon N in SCN1A is due to a specific 
constraint on the role of these channels, rather than a different impact of splicing on channel function. 
In contrast, in SCN2A, the splicing is highly conserved, in spite of the intolerance of this gene to 
variation, suggesting that the change imposed by splicing in SCN2A is not detrimental. 
 
Methods 
Consensus sequences used for Ka/Ks analysis:  
Synthetic „1N variant‟(vr) and „1N ancestral‟(an) sequences used for comparison of variation accrual 
in 23 different genomes. For SCN2A all three changes were silent, and did not change the predicted 
sequence, and for SCN9A both changes observed were also silent. SCN1A contained a mix of silent 
and missense changes. Exons in SCN1A which imposed frameshifts or stop codons were not used for 
this comparison. Only exons predicted to produce full length proteins were used. Thus this analysis 
represents a conservative estimation of the amount of non-synonymous (Ka) changes. 
SCN1A 
An  
GTATGTAACAGAATTTGTAAACCTAGGCAATTTTTCAGCTCTTCGCACTTTCAGAGTCTTGAGAGCTTTGAAAACTATTTCTGT
AATTCCAG 
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Vr  
GGTTTTTAACGAATTTGTAAGATTAGGCAGATTTTCAACTGTCCAAATTTACAGAGTCTTGAGAATTTTGGAACCTATTTCGA
TAGCTCCAG 
SCN2A  
An 
GTATGTAACAGAATTTGTAAACCTAGGCAATGTTTCAGCTCTTCGAACTTTCAGAGTCTTGAGAGCTTTGAAAACTATTTCTG
TAATTCCAG 
Vr 
GTATGTAACAGAATTTGTAAACCTAGGCAATGTTTCAGCTCTTCGCACTTTCAGAGTATTGAGAGCTTTGAAAACTATTTCTG
TAATCCCAG 
SCN9A  
An  
GTATTTAACAGAATTTGTAAACCTAGGCAATGTTTCAGCTCTTCGAACTTTCAGAGTATTGAGAGCTTTGAAAACTATTTCTG
TAATCCCAG 
Vr  
GTATTTAACAGAATTTGTAAACCTAGGCAATGTTTCAGCTCTTCGAACTTTCAGAGTGTTGAGAGCTTTGAAAACTATTTCTG
TAATTCCAG 
 
DNA constructs and Cloning 
Human Nav1.1 cDNAs in the pcDM8 vector were transformed into TOP10/P3 cells. Nav1.2 and 
Nav1.7 cDNAs were in pcDNA3 vectors and transformed into Stbl3 cells. Spontaneous mutagenesis 
of sodium channel gene constructs when propagated in bacterial cultures is not uncommon 
(Mantegazza et al., 2005). To minimize this, incubation temperature of bacterial cultures was kept 
below 30C, and confluence was lower than an OD600 nm value of 0.35. Close monitoring of cell 
growth together with lower temperature conditions and use of a low-copy plasmid reduced mutation 
rate and DNA nicking on sodium channel gene plasmids. Mutation-free cloning was verified for all 
constructs by DNA sequencing. 
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Transfection of HEK-293T cells 
Heterologous expression of splice variants of Nav1.1, Nav1.2 and Nav1.7 was performed in HEK-
293T cells (Chatelier et al., 2008; Fletcher et al., 2011; Thompson et al., 2011). Cells were transiently 
co-transfected with 0.5 µg of the sodium channel plasmid and a reporter EGFP-containing plasmid in 
a 3 : 1 molar ratio using Lipofectamine 2000 (Invitrogen), according to the manufacturer‟s 
instructions. Recordings were performed 36-72 hours after transfection. Non-transfected cells showed 
no detectable sodium currents. 
Whole cell patch clamp recordings in HEK cells 
For all recordings, the extracellular (bath) solution was: (in mM): 135 NaCl, 10 HEPES, 2 MgCl2, 1.8 
CaCl2, 4 KCl, pH 7.35). Intracellular solution was (in mM): 145 CsCl, 5 NaCl, 10 HEPES, 10 EGTA, 
pH 7.35). Liquid junction potential was calculated to be -4.4 mV and was not corrected. Cells were 
patched and all recordings were carried out at physiological temperature (37
o
C +/- 2
o
C). Errors due to 
series resistance were minimized by discarding cells with high series resistance (>3MΩ), large 
currents (>5 nA) or capacitance (>35 pF), but series resistance was not compensated as this 
introduced unacceptable artefacts in these conditions. Peak currents <600 pA were discarded from the 
analysis to avoid distortion by endogenous currents. Data were leak-subtracted using a P/4 protocol. 
HEK cells were held at -80 mV and allowed 4 seconds recovery between depolarizing sweeps. To 
control for variation between transfections, data were collected from at least three different 
transfections. 
Voltage dependence of steady-state activation/inactivation 
Starting from a holding potential of -80mV, cells were stepped to a range of potentials (-120mV to 
+60mV in 10mV increments for 300ms). Normalized conductance values against membrane potential 
were fitted in Origin 8.0 with a Boltzmann function, G/Gmax = 1 / (1 + exp ((V50 - V) / k)) to 
determine the half-maximal channel activation voltage (V50) and the slope factor (k). G/Gmax is the 
normalized conductance value at any given potential (V). 
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The voltage dependence of fast inactivation was determined by measuring the peak sodium current 
during a 30ms test pulse to -10mV, after a 300ms prepulse between -120 to +40mV with 10mV 
increments, starting from a holding potential of -80mV. Peak currents from each step were normalized 
to the maximum response for each cell. Data were fit with a Boltzmann function, INa = (A + (B - A)) 
/ (1 + exp ((V50 - V) / k)), where INa is the fraction of sodium current that is available at any given 
membrane potential (V). 
Stability of inactivation 
Recovery from inactivation was analyzed using a two-pulse protocol with the first pulse (P1, to -10 
mV) lasting 100 ms, and varying time intervals at -80 mV recovery before a second test pulse (P2, to -
10 mV) to measure channel availability. To determine the effects of length of P1 on availability, the 
recovery interval at -80 mV was fixed at 2 ms, and the length of P1 allowed to vary. 
The recovery time course for all three channels was fit by two exponentials [Y0 + AF*(1-exp(-t/τF)) + 
AS*(1-exp(-t/τS))]. Availability after variable inactivating P1 lengths was fit with a first order 
exponential decay (Y0 + A*exp(-t/τ)).   
Statistics 
Results are shown as mean ± s.e.m. Data were tested for normality using the Shapiro-Wilk normality 
test. Normally distributed two sample groups were compared by Student‟s unpaired two-tailed t-test, 
at a significance level of P < 0.05. Sample groups without a normal distribution were compared using 
Fisher‟s exact test (two-tailed). For comparisons of more than two sample groups, ANOVA was used, 
followed by either the Bonferroni's or the Dunnett's test. Fitting used the Levenberg-Marquardt 
algorithm to minimize the χ2 value, with the amplitudes of rates constrained to give positive values. 
Statistical analysis was carried out using the Prism software (GraphPad Software, Inc.), Origin 
(OriginLab) or SPSS (IBM). All modeling was carried out using IonChannelLab (Santiago-Castillo et 
al., 2010). All modifications to rates were constrained to preserve microscopic reversibility in the 
model.  
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Results 
Molecular evolution suggests maladaptive role of the N exon of NaV1.1 in mammals 
First we asked whether the loss of the N exon from mouse and human orthologs of SCN1A  is a 
coincidence, or if loss of this particular exon is more widespread. In humans the expression of this 
exon is reduced by the common rs3812718 polymorphism (Heinzen et al., 2007; Kasperaviciute et al., 
2013; Tate et al., 2005), which disrupts the 5‟ splice site consensus sequence (Zhang, 1998). In mice 
this exon contains frame shifts and stop codons (Gazina et al., 2015), which we confirmed were also 
present in the rat genome. Using the cluster of sodium channel genes in human chromosome 2 (Figure 
1), we identified the N exon in SCN1A in 23 mammalian genomes (Figure 2). The N exon in SCN1A 
had frameshifts and stop codons in seven species (Figure 2). The first voltage-sensing arginine was 
removed from the S4 segment in a further six species, a substitution likely to be damaging for channel 
function (Gosselin-Badaroudine et al., 2012). Only 10 of the 23 species did not contain amino acid 
substitutions that are likely to be deleterious in the N exon (Figure 2). Further evidence for selection 
to reduce the N exon in SCN1A comes from the finding that a splice site polymorphism homologous 
with the human SNP rs3812718 has arisen independently in giant panda (Ailuropoda melanoleuca). 
Does variability in the N exon of SCN1A reflect neutral selection that tolerates changes in the N exons 
of all neuronal sodium channels (making these N exons poorly conserved in general), or is the genetic 
damage specific to SCN1A? To answer this, we identified the corresponding N exons in SCN2A (6N) 
and SCN9A (5N) in the same 23 species and asked whether a similar degree of variation occurred as 
in SCN1A. No species had any amino acid substitutions in either SCN2A or SCN9A, indicating that, 
unlike SCN1A, the N exons in these genes may be subject to selection to remove variation (Figure 2). 
Compared to SCN2A and SCN9A, the number of species with potentially damaging changes in the N 
variant of SCN1A was significantly larger (P < 0.0001; Fisher‟s exact test, correction for multiple 
tests: P < 0.0002, counting rodents as a single ancestral loss).  
To estimate whether the changes in the N exon of SCN1A could be considered indicators of selective 
pressure, or were simply an outcome of genetic drift, we used the pooled data from all of the species 
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where the exon could be aligned to compare the rate of non-synonymous (Ka) and synonymous (Ks) 
changes in this exon (see methods). The Ka/Ks ratio is a proxy for detecting genes under directional 
selection, with a Ka/Ks ratio greater than 1 considered indicative that a gene may be under strong 
selection. This comparison yields a Ka/Ks = 2.4424 for the N exon of SCN1A, and indicates that this 
exon is under strong selective pressure in mammals (Liberles and Wayne, 2002). In contrast, neither 
SCN2A nor SCN9A contain non-synonymous changes in their N exons and consequently their Ka/Ks 
ratio is 0, indicating purifying selection may be stabilizing the N exons in these genes. Thus, the N 
exon in SCN1A appears to be alone in being under strong selection for removal among mammalian 
genomes. This may mean the splicing has a functionally different consequence in SCN1A that is 
deleterious, or that a conserved functional change imposed by splicing has a distinct effect in SCN1A 
because of the role Nav1.1 plays in the nervous system. 
Splicing has little effect on macroscopic currents and voltage dependence 
To ask whether the effects of splicing were similar in different sodium channels, we compared N and 
A splice variants of the three different sodium channels in similar conditions. We used individual 
channels in non-neuronal cells to isolate the effects of splicing on intrinsic properties of pure 
populations of the pore forming subunits of channels. As reported previously, switching exons N and 
A does not have pronounced effects on macroscopic currents or on the voltage dependence of Nav1.1 
or Nav1.7 (Chatelier et al., 2008; Fletcher et al., 2011) (Figure 3). Nav1.2 is a potential outlier, 
because splicing can modify the voltage-dependence of inactivation (Xu et al., 2007), but in our 
recording conditions the voltage-dependence of variants was similar (Figure 3).  
Sodium currents recorded at physiological temperatures represent challenges for voltage clamp 
recordings, and some errors due to series resistance are inevitable. For this reason, as well as keeping 
series resistance low (typically 1-2 MΩ, often below 1 MΩ) and currents small (typically 1-2 nA), we 
employed three additional strategies to control for errors introduced by series resistance, and 
importantly, to ensure series resistance did not introduce artificial differences between splice variants: 
firstly, we carried out all recordings while blinded to variants transfected to reduce bias; secondly, we 
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repeated all recordings with three different sodium channels, and while the different channels clearly 
have different voltage dependencies (as is expected) the splice variants from each individual channel 
did not differ, and thirdly, our plots of the voltage dependencies of activation, which are particularly 
sensitive to failure of control of voltage during steps with excessive series resistance, do not show 
larger variation in the regions near the V½ max where errors due to failure to successfully clamp cells 
increase variability (Figure 3B).  For these reasons, although as for any voltage clamp recording we 
cannot claim to have identified the absolute values of the voltage dependencies of the channels, our 
data are strongly supportive of the relative similarities of splice variants, and confirm the differences 
between Nav1.1, 1.2 and 1.7 (Table 1). 
Effects of splicing on recovery after long inactivating pre-pulses are not conserved 
The N variant of Nav1.1 recovers from 100 ms inactivating pre-pulses more rapidly than the A variant 
(Fletcher et al., 2011). We confirmed this, and asked whether similar effects are imposed by splicing 
in Nav1.2 and Nav1.7 (Figure 4). While Nav1.7 did recover more slowly from inactivating pre-pulses 
overall, the difference between N and A splice variants was conserved for this channel, and was 
similar to that observed in Nav1.1 where the earliest phases of fast recovery from inactivation were 
more pronounced for the N variant than for the A variants. For both Nav1.1 and Nav1.7 the difference 
in recovery was most evident after brief recoveries, and was obscured after longer recovery intervals 
(>100 ms). However, unlike Nav1.1 and Nav1.7, splice variants of Nav1.2 did not reproduce this 
difference in recovery (Figure 4). The N and A variants of Nav1.2 showed similar amounts of 
recovery at all time intervals. This indicates that recovery from inactivation is not a conserved impact 
of alternative splicing, but does not highlight an aspect of splicing that could explain the selectively 
deleterious nature of exon N in Nav1.1, as the change seen for Nav1.1 was also present in Nav1.7. 
Splicing has conserved effects on availability after short depolarizations 
In neurons the most physiologically relevant depolarizations are much shorter than 100 ms. More 
typical action and synaptic potentials last on the order of a few milliseconds. We therefore asked if 
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shorter depolarizations, consistent with brief synaptic currents or action potentials (APs), are able to 
provoke different responses from splice variants of Nav1 channels. An additional reason for focusing 
on shorter inactivating prepusles was the observation that for both Nav1.1 and Nav1.7 where splicing 
did have an effect on recovery, this effect was selective for the fast component (Table 2), suggesting 
splicing may selectively alter fast inactivation, which is rapid both in onset and recovery.  
Indeed, testing recovery after a fixed 2 ms interval after pre-pulse durations between 2 and 50 ms, 
revealed marked differences between splice variants of all three channels, with the N variants 
consistently more available than the A variants (Figure 4). In contrast, longer pre-pulses (>100 ms) 
obscured the differences between the variants of all three channels, further supporting a specific role 
for alternative splicing in modifying fast inactivated states. The difference in availability after short 
pre-pulses was similar (~10 %) across all three channels, in spite of Nav1.7 showing overall less 
availability than Nav1.1 and Nav1.2. Taken together, these data suggest the difference between splice 
variants is due to more rapid availability of the N variants after fast inactivation, a difference which 
can be obscured as longer depolarizations shift the channels into slow inactivated states. The 
conserved nature of the difference imposed by splicing, further supports the possibility that any 
deleterious effect of the N exon in SCN1A is not due to a qualitatively different consequence of that 
exon on Nav1.1 channels per se, but more likely due a deleterious impact arising from the specialized 
role Nav1.1 channels play in the nervous system.  
The N variant of all three channels supports more activity during rapid trains of 
depolarizations  
The different availability after single short depolarizations raises the possibility that splicing can also 
change the ability of sodium channels to open repeatedly during trains of stimuli, such as during 
bursts of APs. To investigate this possibility, we delivered trains of brief depolarizing steps with short 
recovery intervals and compared the availability of the splice variants (Figure 5). Because Nav1.7 did 
not recover sufficiently in with the shortest intervals of 1 ms, variants of this channel were recorded 
with longer recovery intervals of 2 ms.  Indeed, although our holding potential of -80 mV is in the 
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range of physiological potentials where neurons may rest, this potential is within a range where a 
significant portion of Nav1.7 will be in slow inactivated states (Hampl et al., 2016). However, for all 
three channels, the difference in channel availability was evident after a single step and was sustained 
for the entire train, with the A variants remaining less available than the N variants (P < 0.01 for all 
three channels, two-way ANOVA). These results thus imply that splicing may have a conserved role 
in the ability to sustain rapid firing across all three channels. However, given the different amounts of 
slow inactivation for the three channels, in particular for Nav1.7 which has relatively more slow 
inactivation, the overall rate of activity supported by the channels may be different, with either variant 
of Nav1.7 channels being unlikely to support firing at frequencies as rapid as variants of Nav1.1 or 
1.2. Thus while the N variants support approximately 10% more availability for all three channels, 
this 10% increase is imposed upon a different background availability determined by the identity of 
the pore forming subunits.   
For all three channels the difference between variants is occluded by anti-epileptic drugs 
The N and A variants of Nav1.1 have different sensitivities to anti-epileptic drugs (Thompson et al., 
2011). These drugs bind to and stabilize the inactivated states of Nav channels (Kuo and Bean, 1994). 
If the difference in splicing is mediated through a conserved impact of splicing on the stability of 
inactivation, any altered drug response should also be conserved among variants of all three sodium 
channels. We tested this hypothesis, using the same trains of short depolarizations to compare the use-
dependent block by phenytoin and carbamazepine. For all channels the presence of either drug, at 
concentrations within the therapeutic range (Thompson et al., 2011), occluded the difference between 
the splice variants (Figure 5). This is consistent with the splicing having an effect on stability of the 
inactivated states which is occluded by the presence of the drugs that further stabilize inactivated 
states.  
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Modelling suggests splicing in the first domain could change the rate of unbinding of the 
inactivation domain 
How can splicing change the availability of channels after short depolarizations without altering the 
voltage-dependence or macroscopic kinetics of the currents? We used a model of Nav1 channels 
(Carter et al., 2012) to ask whether it is possible, in principle, to reproduce this change in availability 
without altering other kinetic parameters. For simplicity, because the effects of splicing appear 
confined to fast inactivated states, and are obscured by slow inactivated states resulting from longer 
depolarizations, we chose a model which includes only active and fast inactivated states (Figure 6). 
We adjusted the rate constants to match the predicted currents from the model with Nav1.1 currents 
recorded in HEK cells (Figure 6).  
As expected, changes made to most of the transition rates altered both the voltage-dependence and 
macroscopic kinetics of the channels (Figure 7).  For example, altering either α or β, or the voltage 
dependence of up and down movements of each S4 segment, changes macroscopic kinetics (α) and 
voltage dependence of activation (α, and to a lesser extent, β) and steady state inactivation (both α and 
β, Figure 7). Changing γ or δ (pore opening or closing), could change maximal currents (γ), but had 
little effect on stability of inactivation (γ and δ, figure 8).  
However, the rate limiting step determining channel availability after inactivation is the return of the 
fully deactivated channel from the inactivated state (i.e. state 12 in Figure 6), back to the state which 
is fully deactivated and non-inactivated (i.e. state 1 in Figure 6). We found that reducing the rate of 
transitions between states 1 and 12 by a factor of 0.35 was sufficient to change channel availability 
after short inactivating steps but had little or no impact on other parameters (Figure 6,7). This change 
also reproduced the sustained difference in availability during trains of short stimuli in a manner 
qualitatively similar to that seen for splice variants in HEK cells (Figure 7). 
Finally, we asked whether we could model the effects of anti-epileptic drugs. We did this simply by 
further slowing the transitions between states 12 and 1, to mimic the reduced recovery from 
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inactivated states. We imposed a further slowing of 0.01 times the rates for each splice variant, but 
preserved the 0.35-fold difference between the two variants. In these conditions, the model predicted 
that the overall slowing of the anti-epileptic drugs could obscure the difference between the variants 
produced by splicing, and the model predicted channel availability for the variants to be similar both 
in recovering from steps, and in trains of fast steps (Figure 8).  
Thus, our data reveal a general rule for the function of alternative splicing in sodium channel genes, 
and an evolutionary caveat. In three separate channels, we have shown that inclusion of the N exon 
increases channel availability during high frequency stimulation. The conserved nature of this change 
in three different channels suggests the selective pressure against the N exon in SCN1A is due to 
indirect consequences of increasing the availability of Nav1.1 channels.  
 
Discussion  
While splicing in the first domain of sodium channels is generally extremely well conserved, we 
report that in mammalian genomes, SCN1A appears to be under selective pressure in diverse species 
to remove the alternate N exon. Despite this molecular evidence for a maladaptive role of the N exon 
in SCN1A, alternative splicing has a conserved functional effect across human Nav1.1, Nav1.2 and 
Nav1.7 channels. Channels containing the N exon are more available during high frequency trains of 
stimuli, and the differences between variants are occluded by two anti-epileptic drugs that interfere 
with recovery from inactivation. Our modeling suggests that splicing in the D1S3-S4 linker modifies 
the rate at which channels leave the inactivated states. 
At present it is not known why the N exon of SCN1A is being lost in mammals. While sequencing 
studies do support a rapid increase in the disruptive allele of rs3812718 in human populations (the 
ancestral G allele only remains in ~50% of chromosomes), clinical genetics do not suggest a strong 
negative consequence from inclusion of the N exon in humans. In fact despite the widespread 
inclusion of the A allele in human chromosomes, a weak association has been reported suggesting the 
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G allele has a protective effect, conferring reduced risk of epilepsy (particularly epilepsy with febrile 
seizures) in two meta-analysis studies (Baum et al., 2014; Tang et al., 2014). Our results suggest 
expression of the N exon in Nav1.1 may allow more rapid firing of neurons in the face of intense 
synaptic excitation, which given the predominant location of this channel in interneurons (Ogiwara et 
al., 2007; Yu et al., 2006), could help protect against seizure activity, but even if this is the case, this 
protection does not appear sufficient to overcome the evolutionary pressure to remove the N exon 
from mammalian SCN1A.  
Effectively, inclusion of the N exon confers a small gain of function effect on channels by increasing 
their availability. For SCN2A, and SCN9A (and potentially also SCN3A and SCN8A where splicing is 
conserved), this increase in function appears well-tolerated, and even appears strongly conserved in 
mammalian evolution. In contrast, in SCN1A, the change appears detrimental, and because the 
intrinsic changes to the channel are similar for all three genes, it is likely this is due instead to 
constraints on the role of SCN1A. Indeed this gene appears highly intolerant to changes (Lek et al., 
2016). Loss of function in SCN1A is strongly associated with epilepsy, but gain of function mutations 
are also known to be deleterious, as rare mutations with gain of function effects in Nav1.1 are 
associated with familial migraine (Cestèle et al., 2013). This raises the testable hypothesis that the G 
allele of rs3812718 may be associated with altered risk of migraine or with different response of 
migraine to treatment with sodium channel blockers. Our data suggest that revisiting rs3812718 for 
association with diseases other than epilepsy may be informative. 
Splicing at this site is associated with inherited neurological diseases in the other channels as well. 
Splicing in SCN2A modifies the time course of infantile epilepsy (Xu et al., 2007), while splicing in 
SCN9A can change the age of onset of intractable pain (Choi et al., 2010). In mice, removal of the N 
exon in SCN2A in mice leads to a change in seizure threshold (Gazina et al., 2015), and the effects of 
permanent changes in splicing on neuronal circuits in vivo highlight the challenges of translating pure 
biophysical effects in cells to specific consequences in the neuronal milieu where splice variants may 
interact differently with kinases, g-proteins or other modulating pathways. This splicing is co-
regulated in multiple channels both during development (Gazina et al., 2010) and disease (Gastaldi et 
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al., 1997; Tate et al., 2005). In the SCN5A cardiac channels, dysregulated splicing is associated with 
cardiac arrhythmia (Freyermuth et al., 2016). The preservation of this splicing in these genes, despite 
their divergence to different functional roles in distinct cellular populations, strongly suggests that the 
functional role of this splicing supersedes the specialization of each channel.  Although splicing in 
these channels has been studied in isolation (Chatelier et al., 2008; Choi et al., 2010; Fletcher et al., 
2011; Jarecki et al., 2009; Xu et al., 2007), no general rule for its functional consequences has been 
proposed. One reason for the lack of consensus may be because previous studies of NaV1.1 and 
NaV1.7 splice variants at room temperature have shown conflicting results, whereas we show a robust 
increase in availability in the N variant of all three isoforms at physiological temperatures. This 
highlights the importance of performing experiments at elevated temperatures as not all data may be 
extrapolated from room temperature recordings. 
SCN1A may not be the only channel for which more rapid recovery from inactivation produced by the 
aspartate to asparagine switch is deleterious. SCN4A, which encodes Nav1.4 the channel that 
predominates in skeletal muscle, has only transcripts encoding aspartate (equivalent of exon A) at this 
site reported in databases. The N exon appears to have been completely lost in these channels. Finally, 
the TTX-resistant channels encoded by SCN10A and SCN11A also do not have alternative splicing at 
this site; however these channels have much slower macroscopic kinetics of inactivation, and 
consequently may not be sensitive to changes that alter fast inactivated states.  
At the molecular level, the modeling suggests functional specialization of the first the domain of these 
channels. Studies of gating currents have suggested that the voltage sensor in the fourth domain 
(D4S4) is most important for limiting the rate of onset and recovery from inactivation (Capes et al., 
2013). We can now add to what is known about the specialization of the different domains of these 
channels by proposing that the first domain (D1) could be important for release from inactivation. A 
possible mechanistic explanation is that, while the S4 in the fourth domain could be the last to activate 
and thus initiates binding of the inactivation domain (Capes et al., 2013; Chanda and Bezanilla, 2002), 
it is possible that unbinding from D1 may be the rate-limiting step for dissociation of the inactivation 
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domain from the inner side of the deactivated channel. A related, but slightly less well conserved, 
splicing event in the first domain of the cardiac sodium channel (SCN5A/Nav1.5) also affects the 
D1S3-S4 linker. This splicing, which unlike splicing in the neuronal channels incorporates a 
positively-charged lysine in the N exon, has several effects on channel kinetics and voltage 
dependence, as well as slowing recovery from inactivation (Onkal et al., 2008). Thus, in spite of the 
divergence in the sequence of the N exon in cardiac channels, the role of D1 in stability of 
inactivation appears conserved (albeit combined with additional functional effects of splicing not seen 
for neuronal channels in our conditions). Finally, the drive for evolution to exploit the specialized 
roles of the domains of sodium channels to control inactivation is supported by a paralogous splicing 
event in Drosophila changes the S3-S4 linker in the third domain of the sodium channel (Copley, 
2004). Recent work has shown this splicing changes amount of persistent sodium current produced, 
and has pronounced effects on neuronal excitability (Lin et al., 2012). Thus splicing in D3 suggests 
this domain may regulate the total amount of inactivation, rather than its rate of onset or release.  
In spite of the conserved effects on channel availability, we cannot rule out other roles for this 
splicing in contributing to distinct functions in different neuronal populations, or in regulating 
interactions with other proteins. For example, in Nav1.7, splicing has been shown to modify 
phosphorylation (Chatelier et al., 2008) and interactions with β subunits (Farmer et al., 2012). 
Our data suggest there is a general rule that alternative splicing in the DIS3-S4 linker of neuronal 
sodium channels modifies their availability after short depolarizations, implicate the first domain in 
determining channel availability, and predict that similar effects will be found in SCN3A and SCN8A 
for this splice site. 
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Translational Perspective 
Splicing in SCN1A leads to increased channel availability and may be detrimental in mammalian 
nervous systems. This is consistent with recent findings suggesting mutations linked to gain of 
function in this gene can cause migraine. Splicing may also affect migraine and its treatment. This is 
particularly relevant as many patients may have a common polymorphism that changes the ratio of 
splice variants in SCN1A, and which may affect the dosage of some drugs that have been used to treat 
migraine (e.g. carbamazepine). Our work raises the hypothesis that there may be a genetic association 
between SNPs in SCN1A that alter splicing and susceptibility to migraine, with genotypes favoring 
inclusion of the „N‟ or „neonatal‟ exon increasing risk. Splicing also interacts with pharmacology in a 
manner that suggests many sodium channels may be more affected by common anti-epileptic drugs 
after seizures. Potential strategies for targeting splice variants rather than different types of channels 
may be valuable routes forward for developing more selective sodium channel drugs which could be 
more effective in tissue where the N exons are broadly upregulated.  
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Tables 
Table 1: Voltage dependence of activation and steady state inactivation for splice variants are 
similar 
 Nav1.1 Nav1.2 Nav1.7 
  A s.e.m N s.e.m. A s.e.m N s.e.m. A s.e.m N s.e.m. 
V1/2 act 
(mV) 
-16.5 1.4 -17.9 1.9 -21.5 3.7 -21.3 1.4 -15.9 2.5 -16.2 3 
V1/2 inact 
(mV) 
-55.4 1.1 -55.1 2.4 -61.2 1.6 -62.9 2.4 -71.8 3.6 -74.3 3.9 
n 6   6   9   7   6   7   
 
Table 2A: Parameters of single exponential fits describing channel availability after 2 ms 
recovery from pre-pulses of different durations. Fits were carried out with all parameters allowed 
to vary. To better compare the goodness of fits with the different degrees of freedom the adjusted R-
square statistic (R 2) is given. In this instance only the amplitude (A) differed significantly between the 
two variants. The confidence intervals for the other parameters (Y0 and τ) overlapped. 
 Nav1.1-N Nav1.1-A Nav1.2-N Nav1.2-A Nav1.7-N Nav1.7-A 
 Value s.e. Value s.e. Value s.e. Value s.e. Value s.e. Value s.e. 
Y0 0.22 0.02 0.19 0.02 0.13 0.02 0.13 0.01 0.18 0.01 0.14 0.01 
A 0.640 0.022 0.547 0.018 0.764 0.012 0.689 0.014 0.323 0.012 0.243 0.010 
τ (ms) 155 13 164 15 111 10 106 8 98 10 92 9 
  2 0.991  0.989  0.992  0.993  0.977  0.972  
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Table 2B. Parameters of bi-exponential fits to recovery from long (100 ms) inactivating pre-
pulses. R 2 is the adjusted R-square statistic used to improve comparison of fits with different degrees 
of freedom. The requirement for two exponentials to adequately fit recovery from inactivation is 
consistent with a fast and a slow component of recovery from inactivation, with the slow component 
poorly defined in our conditions. 
 Nav1.1-N Nav1.1-A Nav1.2-N Nav1.2-A Nav1.7-N Nav1.7-A 
 Value s.e. Value s.e. Value s.e. Value s.e. Value s.e. Value s.e. 
Y0 0.044 0.040 0.003 0.036 0 0.081 0 0.069 0.079 0.007 0.012 0.009 
AF 0.65 0.04 0.67 0.36 0.73 0.08 0.71 0.06 0.78 0.01 0.79 0.02 
τF 
(ms) 
1.5 0.2 1.9 0.2 1.1 0.2 1.0 0.2 8.7 0.4 8.9 0.6 
AS 0.23 0.03 0.25 0.03 0.20 0.04 0.20 0.04 0.07 0.01 0.12 0.02 
τS 
(ms) 
218 69 272 95 315 202 541 559 273 139 265 100 
  2 0.994  0.994  0.978  0.981  0.999  0.999  
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Figure legends: 
Figure 1: The conserved cluster of sodium channel genes on human chromosome 2  
A schematic indicating the relative positions of SCN1A, SCN2A, SCN3A and SCN9A in the conserved 
cluster on chromosome 2. In some mammalian genomes the numbering and annotation of SCN2A, 
SCN3A and SCN1A are inconsistent. In order to unambiguously identify the exon homologous to the 
N exon in human SCN1A, the identity of the sodium channel gene containing it was verified using its 
position relative to the other genes in the cluster, and according to the direction of transcription. The 
arrow labeled G3 indicates the position and orientation of the GALNT3 gene which is conserved at 
this site in mammals. All aligned sequences of N exons are available upon request. 
 
 
Figure 2: The N exon has been destroyed in multiple mammalian copies of SCN1A  
(A) Cartoon indicating the site of the single amino acid changed in the short extracellular linker 
between the third and fourth transmembrane segments in domain 1 (D1 S3-S4, arrow). The overall 
length of these channels is typically >2000 amino acids. The region outlined in black corresponds to 
the entire sequence encoded by the alternate exons, including the voltage sensor in the first domain.  
(B) The conserved splicing motif in the first domain of sodium channels. Introns (thin black lines) and 
exons (squares) are to scale. In all cases the N exon precedes the A exon and they are separated by a 
short intron. Similar architecture is present in SCN3A, SCN5A and SCN8A, which also arose from 
duplications during vertebrate evolution. Numbers correspond to the current annotation of exons in 
Ensembl and NCBI. 
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(C) The identical sequences encoded by the A exons in human SCN1A (1A, top), SCN2A (2A, middle) 
and SCN9A (9A, bottom). The aspartate (D) which is consistently changed to a neutral amino acid 
(serine, S, or asparagine, N) is indicated by the box. 
(D) The sequences encoded by the N exons in SCN2A (2A, top) and SCN9A (9A, bottom). In these 
two genes the sequences encoded by the N exons are identical in all 23 mammalian genomes 
surveyed. Only silent changes are observed, with 3 silent changes seen for all 23 copies of SCN2A 
and 2 changes seen in SCN9A (see methods).  
(E-F) The sequences encoded by the N exon in SCN1A (NaV1.1) for 23 mammalian species where 
this exon could be un-ambiguously identified. With full length sequences aligned (E), and truncated 
exons not aligned (F). The changes in (E) are highlighted according to functional impact: 
conservative (green), not conservative (yellow), loss of an S4 arginine (purple). In some cases (Oc, 
Og, Cp, Cg, Mm, Rn) the exon could not be identified using standard megaBLAST parameters and 
the location of the N exon was ascertained using its proximity to the A exon in SCN1A (as described 
in B, and figure 1). It was not possible to identify the N or A exons in SCN1A from Sus scrofula. 
Species: Cj Callithrix jacchus; Hs Homo sapiens; Mml Macaca mulatta; Nl Nomascus leucogenys; 
Og Otolemur garnettii; Pp Pan paniscus; Pt Pan troglodytes; Pan Papio anubis; Pab Pongo abelii; Sb 
Saimiri boliviensis; Gg Gorilla gorilla; Cp Cavia porcellus; Cg Cricetulus griseus; Mms Mus 
musculus; Rn Rattus norvegicus; Am Ailuropoda melanoleuca; Bt Bos taurus; Cl Canis lupus; Ec 
Equus caballus; Fc Felis cattus; Oc Oryctolagus cuniculus; Oa Ovis aries; La Loxodonta Africana. 
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Figure 3: Splicing does not alter macroscopic kinetics or voltage dependence  
(A) Representative traces from HEK cells expressing A (black) and N (blue) variants of Nav1.1 (left), 
Nav1.2 (middle) and Nav1.7 (right) evoked by a 2 ms step from -80 mV to -10 mV. Macroscopic 
properties of the currents were largely indistinguishable for individual traces. Currents are from cells 
selected to have similar peak currents for comparison, but are not scaled.  
(B) Voltage dependence of steady state inactivation (N = red and A = black) and activation (N = blue 
and A = black) for splice variants are similar and not robustly affected by splicing in any of the three 
channels in these conditions (Table 1).  
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Figure 4: Splicing has a conserved effect on channel availability after inactivation  
(A) For both Nav1.1 (left) and 1.7 (right), N variants showed more recovery than A variants after 
short intervals. Variants of Nav1.2 (middle) were not different. Values for all fits are in Table 2B. 
Nav1.1 A n = 10, N n = 9; Nav1.2 A n = 7, N n = 6; Nav1.7 A n = 5, N n = 8. 
(B) The N variants of all three channels showed significantly more availability after shorter pre-pulses 
(*** Two-way ANOVA, p < 0.001). The curves shown were fit with single exponentials with the 
offset and rates fixed (all rates from free fits are given in Table 2A). Only the amplitude of the 
exponential was significantly different for the splice variants (i.e. the proportion of channels 
inactivating with this fast time course, as opposed to slow inactivated states, for example). Nav1.1 A n 
= 6, N n = 6; Nav1.2 A n = 10, N n = 9; Nav1.7 A n = 7, N n = 10.  
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Figure 5: Splicing changes response to fast trains of stimuli and has consistent effects on 
pharmacology of all three channels 
(A) N variants of all three channels are able to support larger currents during rapid trains of 
depolarizing steps. The first step in all cases was normalized to 100%, with responses to the following 
steps shown scaled. The difference between variants was consistent for all three channels and 
persisted for the duration of the train (*** Two-way ANOVA, p < 0.0001). Nav1.1 A n = 8, N n = 8; 
Nav1.2 A n = 11, N n = 9; Nav1.7 A n = 6, N n = 8. The recovery intervals used were 1 ms for Nav1.1 
and Nav1.2, but 2 ms was allowed for Nav1.7 channels, which show little current after a 1 ms 
recovery.   
(B,C) Addition of either phenytoin (B) or carbamazepine (C) to Nav1.1, Nav1.2, or Nav1.7 reduces 
channel availability after the first step, and obscures the difference between splice variants during the 
train (ns P > 0.05, Two-way ANOVA). Each drug was applied at 30 µM, a concentration which 
approximates half maximal inhibition (Thompson et al., 2011). 
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Figure 6. A model of sodium channel gating indicates that modification of a single gating step may 
be sufficient to modify channel availability without altering other parameters.  
(A) The scheme, as adapted from Carter et al., (2012) and adjusted for our human Nav1.1 channels 
recorded in HEK cells at 37
o
C. The top left position (#1) corresponds to resting, closed channels with 
all four voltage sensors down (de-activated) and the inactivation domain off (i.e. channels are not 
inactivated, or are de-inactivated). The only state which passes current is state #6 (top right), which 
channels briefly visit upon depolarization. The bottom row of states (#7-12) all have the inactivation 
domain bound („on‟). The two splice variants of Nav1.1 were modeled by changing the rate at which 
channels move between states #1 and #12 (i.e. the rate at which the inactivation domain binds to or is 
released from the inner pore of channels with all four voltage sensors in the resting, „down‟, 
configuration). The transitions for A variants are 0.35 times the rates for transitions between these 
states for the N variants (exact values: A(1-12) = 0.01*350 s
-1
; N(1-12) = 0.01*1000 s
-1
; A(12-1) = 
2.5*350 s
-1
; N(12-1) = 2.5*1000 s
-1
).  
(B) The model accurately predicts macroscopic currents produced by either splice variant of Nav1.1. 
A = thin black line, N = thin blue line, model = thick grey line overlay. Macroscopic currents 
predicted by the model for both variants during a single step were identical.  
(C) Changing the rate of transitions between states 12 and 1 is able to replicate the increased 
availability of the N variant relative to the A variant after short inactivating pre-pulses of variable 
duration. Note that the predicted currents in response to the initial step are identical (the blue traces 
exactly overlay the black traces during the response to the first step). 
(D) The full rates used for the model for the N variant of Nav1.1. Rates for the adult variant were 
identical except for the transitions between states 12 and 1. Note the units are in seconds for these 
rates. 
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Figure 7:  Changing transitions between states 12 and 1 reproduces differences seen with 
splicing, while changing most other rates affect multiple parameters 
(A) Changing the transitions between states 12 and 1, as described in figure 6, alters availability 
during a train of brief depolarizations (left) but does not change voltage dependence of activation and 
inactivation or the macroscopic kinetics of currents (middle). The predicted voltage dependence of 
activation and steady state inactivation were identical for both variants. Both black (A) and blue (N) 
lines are shown, but overlay exactly. This parameter is also sufficient to reproduce the altered change 
in rate of recovery from fast inactivation (right). 
(B) Changing the rate of S4 movement in response to depolarization (α) by 50% does change the 
availability of channels during fast trains of pulses, but this parameter also changes rate of activation 
during a voltage step , and voltage dependence of both steady state inactivation and activation. The 
effect on recovery from inactivation is minimal. 
(C) Altering the voltage dependence of downward movements of S4 segments (β) has marked effects 
on availability during fast trains of steps (left), and recovery from inactivation (right), but also 
changes the voltage dependence of steady state inactivation (middle). 
  
 
 
This article is protected by copyright. All rights reserved. 
 
(D) Changing the rate of pore opening (γ) changes the total availability of channels (note initial peak 
is different, left panel, arrow), but has relatively modest effects on availability during trains of activity 
(left), and scaling the initial peaks removes the difference in recovery from inactivation (right).  
(E) Altering the rate of pore closing (δ) has very small effects on availability during trains (left), as 
well as small effects on both voltage dependence of inactivation (middle) and recovery (right). The 
effects of changing δ are likely small because most channels inactivate before closing.  
Currents predicted with the A values are in black throughout. The horizontal scale is the same 
throughout, and vertical scale represents proportion of simulated channels activated.  
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Figure 8: Modelling effects of anti-epileptic drugs can obscure the differences predicted by 
splicing 
(A) The predicted reduction in recovery as the transitions between states 1 and 12 are further slowed 
by a factor of 0.01. Note that in the presence of the modelled „PHT‟ the response to predicted 4th step 
is identical for rates for both the N and A variants. The response predicted for the N variant in absence 
of the „PHT‟ effect is shown for comparison, where the 4th interval has recovered to a much greater 
extent. 
(B) The slowing of the modelled „PHT‟ effect eradicates the difference between the two splice 
variants predicted by the model. The initial predicted responses are as in Figure 8, but the further 
reduction in availability is overlaid. Both the N + PHT and A + PHT overlay exactly in this panel. 
 
 
